Question 1

What is PT-141 (Bremelanotide)?

Accepted Answer

PT-141 (Bremelanotide) is a synthetic peptide that works as a melanocortin receptor agonist. It activates MC3R and MC4R receptors in the hypothalamus to enhance sexual desire and arousal in both men and women. Unlike Viagra or Cialis, PT-141 works through the central nervous system rather than the vascular system.

Question 2

How quickly does PT-141 work?

Accepted Answer

PT-141 typically begins working within 30 to 60 minutes of subcutaneous administration. Effects can last up to 24 hours, though individual response times may vary based on dosage and individual physiology.

Question 3

Is PT-141 safe for women?

Accepted Answer

Yes. Bremelanotide is FDA-approved as Vyleesi for the treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women. It has been studied in multiple clinical trials demonstrating both efficacy and an acceptable safety profile.

Question 4

Does PT-141 require a prescription?

Accepted Answer

Yes, PT-141 (Bremelanotide) is a prescription medication. All patients must complete a consultation with a licensed healthcare provider before a prescription can be issued. PT-141.com connects patients with board-certified providers who specialize in peptide-based sexual wellness therapies.

Question 5

What is the difference between PT-141 and Viagra?

Accepted Answer

PT-141 (Bremelanotide) and Viagra (sildenafil) work through completely different mechanisms. Viagra works on the vascular system to increase blood flow, helping with physical erection. PT-141 works on the central nervous system, specifically the hypothalamus, to increase sexual desire and arousal at a neurological level. PT-141 is also effective for women, while Viagra is not approved for female sexual dysfunction.

FAQ | PT-141.com